Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom.

Ghani A, Baguelin M, Griffin J, Flasche S, van Hoek AJ, Cauchemez S, Donnelly C, Robertson C, White M, Truscott J, Fraser C, Garske T, White P, Leach S, Hall I, Jenkins H, Ferguson N, Cooper B.

Version 2. PLoS Curr. 2009 Nov 16 [revised 2010 Jun 13];1:RRN1130. No abstract available.

2.

Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.

Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, Vachon J, Gonzalez C, Hongjie Y, Zijian F, Chuang SK, Au A, Buda S, Krause G, Haas W, Bonmarin I, Taniguichi K, Nakajima K, Shobayashi T, Takayama Y, Sunagawa T, Heraud JM, Orelle A, Palacios E, van der Sande MA, Wielders CC, Hunt D, Cutter J, Lee VJ, Thomas J, Santa-Olalla P, Sierra-Moros MJ, Hanshaoworakul W, Ungchusak K, Pebody R, Jain S, Mounts AW; WHO Working Group for Risk Factors for Severe H1N1pdm Infection.

PLoS Med. 2011 Jul;8(7):e1001053. doi: 10.1371/journal.pmed.1001053. Epub 2011 Jul 5.

3.

H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.

Kumar S, Fan J, Melzer-Lange M, Trost J, Havens PL, Willoughby RE, Chusid MJ, Henrickson KJ.

Pediatr Emerg Care. 2011 Sep;27(9):804-7. doi: 10.1097/PEC.0b013e31822c125e.

PMID:
21878831
4.

The early diversification of influenza A/H1N1pdm.

Nelson M, Spiro D, Wentworth D, Beck E, Fan J, Ghedin E, Halpin R, Bera J, Hine E, Proudfoot K, Stockwell T, Lin X, Griesemer S, Kumar S, Bose M, Viboud C, Holmes E, Henrickson K.

PLoS Curr. 2009 Nov 3;1:RRN1126.

5.

Altered specificity of single-chain antibody fragments bound to pandemic H1N1-2009 influenza virus after conversion of the phage-bound to the soluble form.

Kaku Y, Noguchi A, Okutani A, Inoue S, Tanabayashi K, Yamamoto Y, Hotta A, Suzuki M, Sugiura N, Yamada A.

BMC Res Notes. 2012 Sep 4;5:483. doi: 10.1186/1756-0500-5-483.

6.

Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis.

Baillie GJ, Galiano M, Agapow PM, Myers R, Chiam R, Gall A, Palser AL, Watson SJ, Hedge J, Underwood A, Platt S, McLean E, Pebody RG, Rambaut A, Green J, Daniels R, Pybus OG, Kellam P, Zambon M.

J Virol. 2012 Jan;86(1):11-8. doi: 10.1128/JVI.05347-11. Epub 2011 Oct 19.

7.

Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean Sea, May-September 2009.

Tarabbo M, Lapa D, Castilletti C, Tommaselli P, Guarducci R, Lucà G, Emanuele A, Zaccaria O, La Gioia VF, Girardi E, Capobianchi MR, Ippolito G.

PLoS One. 2011 Jan 20;6(1):e15933. doi: 10.1371/journal.pone.0015933.

8.

Amino acids transitioning of 2009 H1N1pdm in Taiwan from 2009 to 2011.

Chen GW, Tsao KC, Huang CG, Gong YN, Chang SC, Liu YC, Wu HH, Yang SL, Lin TY, Huang YC, Shih SR.

PLoS One. 2012;7(9):e45946. doi: 10.1371/journal.pone.0045946. Epub 2012 Sep 24.

9.

H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.

Souza TM, Salluh JI, Bozza FA, Mesquita M, Soares M, Motta FC, Pitrowsky MT, de Lourdes Oliveira M, Mishin VP, Gubareva LV, Whitney A, Rocco SA, Gonçalves VM, Marques VP, Velasco E, Siqueira MM.

PLoS One. 2010 Nov 30;5(11):e14158. doi: 10.1371/journal.pone.0014158.

10.

Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009.

Graham M, Liang B, Van Domselaar G, Bastien N, Beaudoin C, Tyler S, Kaplen B, Landry E; National Influenza A/H1N1pdm Genomics Study Team (NIGST), Li Y.

PLoS One. 2011 Jan 7;6(1):e16087. doi: 10.1371/journal.pone.0016087.

11.

The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination.

Nakajima N, Hata S, Sato Y, Tobiume M, Katano H, Kaneko K, Nagata N, Kataoka M, Ainai A, Hasegawa H, Tashiro M, Kuroda M, Odai T, Urasawa N, Ogino T, Hanaoka H, Watanabe M, Sata T.

Jpn J Infect Dis. 2010 Jan;63(1):67-71.

12.

Reliability of a newly-developed immunochromatography diagnostic kit for pandemic influenza A/H1N1pdm virus: implications for drug administration.

Sasaki T, Kubota-Koketsu R, Takei M, Hagihara T, Iwamoto S, Murao T, Sawami K, Fukae D, Nakamura M, Nagata E, Kawakami A, Mitsubayashi Y, Ohno M, Uehara Y, Fukukawa T, Kanai Y, Kosaka M, Ikuta K.

PLoS One. 2012;7(11):e50670. doi: 10.1371/journal.pone.0050670. Epub 2012 Nov 30.

13.

Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa.

Van Kerkhove MD, Mounts AW, Mall S, Vandemaele KA, Chamberland M, dos Santos T, Fitzner J, Widdowson MA, Michalove J, Bresee J, Olsen SJ, Quick L, Baumeister E, Carlino LO, Savy V, Uez O, Owen R, Ghani F, Paterson B, Forde A, Fasce R, Torres G, Andrade W, Bustos P, Mora J, Gonzalez C, Olea A, Sotomayor V, Najera De Ferrari M, Burgos A, Hunt D, Huang QS, Jennings LC, Macfarlane M, Lopez LD, McArthur C, Cohen C, Archer B, Blumberg L, Cengimbo A, Makunga C, McAnerney J, Msimang V, Naidoo D, Puren A, Schoub B, Thomas J, Venter M; WHO Southern Hemisphere Influenza Comparison Study Working Group.

Influenza Other Respir Viruses. 2011 Nov;5(6):e487-98. doi: 10.1111/j.1750-2659.2011.00249.x. Epub 2011 Apr 20. Review.

14.

Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferrets.

Suguitan AL Jr, Zengel JR, Jacobson S, Gee S, Cetz J, Cha P, Chen Z, Broome R, Jin H.

Influenza Other Respir Viruses. 2014 Mar;8(2):169-76.

15.

Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract.

Chan MC, Chan RW, Yu WC, Ho CC, Yuen KM, Fong JH, Tang LL, Lai WW, Lo AC, Chui WH, Sihoe AD, Kwong DL, Wong DS, Tsao GS, Poon LL, Guan Y, Nicholls JM, Peiris JS.

Am J Pathol. 2010 Apr;176(4):1828-40. doi: 10.2353/ajpath.2010.091087. Epub 2010 Jan 28.

16.

Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates.

Weinfurter JT, Brunner K, Capuano SV 3rd, Li C, Broman KW, Kawaoka Y, Friedrich TC.

PLoS Pathog. 2011 Nov;7(11):e1002381. doi: 10.1371/journal.ppat.1002381. Epub 2011 Nov 10.

17.

Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.

Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, Leόn AJ, Ng DC, Almansa R, Martin-Loeches I, Ramirez P, Socias L, Loza A, Blanco J, Sansonetti P, Rello J, Andaluz D, Shum B, Rubino S, de Lejarazu RO, Tran D, Delogu G, Fadda G, Krajden S, Rubin BB, Bermejo-Martin JF, Kelvin AA, Kelvin DJ.

PLoS One. 2012;7(6):e38214. doi: 10.1371/journal.pone.0038214. Epub 2012 Jun 5.

18.

Design and clinical application of a molecular method for detection and typing of the influenza A/H1N1pdm virus.

Lalle E, Bordi L, Castilletti C, Meschi S, Selleri M, Carletti F, Lapa D, Travaglini D, Ippolito G, Capobianchi MR, Di Caro A.

J Virol Methods. 2010 Feb;163(2):486-8. doi: 10.1016/j.jviromet.2009.10.004. Epub 2009 Oct 25.

PMID:
19836420
19.

Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus.

Pan C, Cheung B, Tan S, Li C, Li L, Liu S, Jiang S.

PLoS One. 2010 Mar 8;5(3):e9549. doi: 10.1371/journal.pone.0009549.

20.

Reliability of a rapid test for the clinical diagnosis of influenza A/H1N1 2009.

Harada D, Nishiuchi R, Iwasaki Y, Watanabe H, Tokorodani C, Kanazawa A, Kiguchi H, Gotoh S, Miyazawa M, Nakata Y, Morishima T, Kikkawa K.

Scand J Infect Dis. 2012 Oct;44(10):776-81. Epub 2012 Jul 17.

PMID:
22803629
Items per page

Supplemental Content

Write to the Help Desk